SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (9205)9/25/2003 8:59:20 AM
From: IRWIN JAMES FRANKEL  Read Replies (1) | Respond to of 52153
 
The NBIX news was released after the close at 4:02ET.



To: tom pope who wrote (9205)9/25/2003 9:03:51 AM
From: Biomaven  Respond to of 52153
 
NBIX sold off in the face of the Indiplon news.

It's very hard to disentangle the overall biotech profit-taking yesterday from the reaction to specific stock news. Arguably if people thought the NBIX results were poor, then SEPR should have been strong, which it manifestly was not.

NBIX results looked very good to me, with the only caution being the drop-off in week 2, partly due to the placebo improving in week 2.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News